Pharmetro Life Sciences Private Limited
About Pharmetro Life Sciences Private Limited
Data last updated:
Pharmetro Life Sciences Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24239UP2019PTC114440.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Aditya Jhunjhunwala and Rajiv Gupta.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 76 Eldeco Greens Gomtinagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2024, the company reported a revenue of ₹60,824, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹42,068 (net margin 69.2%) and EBITDA of ₹56,875 (EBITDA margin 93.5%). Revenue has grown at a compounded annual rate (CAGR) of 72% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address76 Eldeco Greens Gomtinagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Pharmetro Life Sciences Private Limited FY 2025 filings available
Pharmetro Life Sciences Private Limited reported revenue of ₹60,824 (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pharmetro Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 72% over three years, including 17% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pharmetro Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹56,875 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹42,068 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pharmetro Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 93.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 69.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pharmetro Life Sciences are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pharmetro Life Sciences Private Limited
Pharmetro Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Its own revenue is ₹60,824.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pushkar Pharmaceuticals Pvt Ltd | ₹63,000 | •••• | •••• | •••• | - | U T, Chandigarh, India |
| Emsons Pharmaceuticals Pvt Ltd | ₹62,450 | •••• | •••• | •••• | - | Kol, West Bengal, India |
| Cellix Bio Private Limited | ₹61,900 | •••• | •••• | •••• | - | Tirumalagiri, Telangana, India |
| Avaca Pharma Private Limited | ₹61,895 | •••• | •••• | •••• | - | Guntur, Andhra Pradesh, India |
| Adney Formulations Private Limited | ₹61,000 | •••• | •••• | •••• | - | Vasai, Maharashtra, India |
| Pharmetro Life Sciences Private Limited this company | ₹60,824 | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
| Nirmaya Laboratories Private Limited | ₹60,199 | •••• | •••• | •••• | - | Vadodara, Gujarat, India |
| Modern Fastners Pvt Ltd | ₹60,000 | •••• | •••• | •••• | - | Chandigarh, India |
| Nubiotic Pharmaceuticals Private Limited | ₹59,207 | •••• | •••• | •••• | - | Patna, Bihar, India |
| Hindustan Bio-Tech- Limited | ₹59,000 | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Reelox Pharmaceutical Private Limited | ₹58,441 | •••• | •••• | •••• | - | Kushi Nagar, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Pharmetro Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and growth of each peer are in the company report.
Board of Directors of Pharmetro Life Sciences Private Limited
Pharmetro Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Jhunjhunwala Also directs: K M Sugar Mills Limited, KM Spirits and Allied Industries Limited, Sonar Casting Limited and 5 more | Director | 07 Mar 2019 | 7 Years 7 Months | Current |
| Rajiv Gupta | Director | 07 Mar 2019 | 7 Years 7 Months | Current |
Ownership and Shareholding of Pharmetro Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharmetro Life Sciences Private Limited
Pharmetro Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Pharmetro Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Pharmetro Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pharmetro Life Sciences Private Limited
Pharmetro Life Sciences Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Aditya Jhunjhunwala was appointed as Director on 07 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for Pharmetro Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharmetro Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmetro Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharmetro Life Sciences Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmetro Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmetro Life Sciences Private Limited
Pharmetro Life Sciences is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 March 2019 (7+ years old) and is registered under CIN U24239UP2019PTC114440.
Pharmetro Life Sciences reported revenue of ₹60,824 for FY 2024 (up 17% YoY).
Pharmetro Life Sciences has 2 current directors:
- Aditya Jhunjhunwala - Director
- Rajiv Gupta - Director
Pharmetro Life Sciences reported a net profit of ₹42,068 (net margin 69.2%) and EBITDA of ₹56,875 (EBITDA margin 93.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pharmetro Life Sciences is 72% over three years. In the latest year (FY 2024) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Pharmetro Life Sciences is U24239UP2019PTC114440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmetro Life Sciences was incorporated on 07 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Pharmetro Life Sciences by revenue are Pushkar Pharmaceuticals Pvt Ltd, Emsons Pharmaceuticals Pvt Ltd, Cellix Bio Private Limited, Avaca Pharma Private Limited, Adney Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Aditya Jhunjhunwala was appointed as Director on 07 Mar 2019. Rajiv Gupta was appointed as Director on 07 Mar 2019.
The registered office of Pharmetro Life Sciences is at 76 Eldeco Greens Gomtinagar, Lucknow, Uttar Pradesh, India – 226010.
Pharmetro Life Sciences has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.